White blood cell count and risk of gastric cancer incidence in a general Japanese population

American Journal of Epidemiology

Volumn 175, Issue 6, 2012, Pages 504-510

  Iida, Masahiro ^a   Ikeda, Fumie ^a   Ninomiya, Toshiharu ^a   Yonemoto, Koji ^b   Doi, Yasufumi ^a   Hata, Jun ^a   Matsumoto, Takayuki ^a   Iida, Mitsuo ^a   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; inflammation; leukocytes; proportional hazards models; prospective studies; risk factors; stomach neoplasms

Indexed keywords

BACTERIUM; BASELINE CONDITIONS; BLOOD; CANCER; CYTOLOGY; DISEASE INCIDENCE; HEALTH RISK; HETEROGENEITY; PUBLIC HEALTH; RISK FACTOR;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; JAPANESE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER;

ADULT; AGED; DIET; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

JAPAN;

HELICOBACTER PYLORI;

EID: 84858382892     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr345     Document Type: Article

References (41)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. (IARC CancerBase no. 5, version 2.0). Lyon, France: IARC Press; 2004.
2. Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer. 1992;70(5): 1030-1037.
3. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama Study. Arch Intern Med. 2000;160(13):1962-1968. (Pubitemid 30437580)
4. Shikata K, Doi Y, Yonemoto K, et al. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol. 2008; 168(12):1409-1415.
5. Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology. 2009; 136(4):1234-1241.
6. Asano K, Kubo M, Yonemoto K, et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int J Cancer. 2008;122(4):909-914.
7. Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer. 2006; 119(1):196-201.
8. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-789.
9. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med. 2005;165(5):500-508. (Pubitemid 40344380)
10. Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004;17(3):233-239. (Pubitemid 38293328)
11. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353(9165):1649-1652. (Pubitemid 29224520)
12. Margolis KL, Rodabough RJ, Thomson CA, et al. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007;167(17): 1837-1844. (Pubitemid 47481478)
13. Lee YJ, Lee HR, Nam CM, et al. White blood cell count and the risk of colon cancer. Yonsei Med J. 2006;47(5):646-656.
14. Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1052-1056. (Pubitemid 38756717)
15. Ohmura T, Ueda K, Kiyohara Y, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia. 1993;36(11):1198-1203. (Pubitemid 23314572)
16. Ministry of Health and Welfare of Japan. The Results of the National Nutrition Survey in 1989 [in Japanese]. Tokyo, Japan: Dai-Ichi Shuppan Publishing; 1991.
17. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer. 1998;1(1):10-24.
18. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
19. Rappaport ES, Helbert B, Beissner RS, et al. Automated hematology: where we stand. South Med J. 1988;81(3): 365-370.
20. Shirota T, Yoshizumi E. Accuracy of nutritional survey using the simple method [in Japanese]. Jpn J Public Health. 1990; 37:100-108.
21. Resources Council of the Science and Technology Agency. Standard Tables of Food Composition in Japan. 4th ed. Tokyo, Japan: Ministry of Finance Printing Bureau; 1982.
22. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1): 17-27. (Pubitemid 16095831)
23. Cox DR. Regression models and life-tables [with discussion]. J R Stat Soc Ser B Methodol. 1972;34(2):187-220.
24. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20(4):633-649. (Pubitemid 44391336)
25. Vittinghoff E, Glidden DV, Shiboski SC, eds. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer Publishing Company; 2005.
26. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985;254(14):1932-1937. (Pubitemid 15249094)
27. Shankar A,Wang JJ, Rochtchina E, et al. Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med. 2006; 166(2):188-194. (Pubitemid 43144942)
28. Jee SH, Park JY, Kim HS, et al. White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans. Am J Epidemiol. 2005;162(11): 1062-1069.
29. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735-6740. (Pubitemid 23006271)
30. Karttunen TJ, Niemelä S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci. 1996;41(7): 1332-1336. (Pubitemid 26245912)
31. Yamaoka Y, Kita M, Kodama T, et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997; 41(4):442-451.
32. Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14(11):2487-2493. (Pubitemid 41752706)
33. Kim JS, Jung HC, Kim JM, et al. Interleukin-8 expression by human neutrophils activated by Helicobacter pylori soluble proteins. Scand J Gastroenterol. 1998;33(12):1249-1255. (Pubitemid 29046529)
34. Wozniak A, Betts WH, Murphy GA, et al. Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology. 1993;79(4):608-615. (Pubitemid 23246899)
35. Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halidedependent formation of hydroxyl radical. Biochemistry. 2000; 39(18):5474-5482. (Pubitemid 30257089)
36. Ohshima H, Tazawa H, Sylla BS, et al. Prevention of human cancer by modulation of chronic inflammatory processes. Mutat Res. 2005;591(1-2):110-122. (Pubitemid 41654843)
37. Mooney C, Keenan J, Munster D, et al. Neutrophil activation by Helicobacter pylori. Gut. 1991;32(8):853-857.
38. Baik SC, Youn HS, Chung MH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 1996;56(6):1279-1282.
39. Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut. 1998;42(3): 351-356. (Pubitemid 28197023)
40. Hisamichi S. Screening for gastric cancer. World J Surg. 1989; 13(1):31-37. (Pubitemid 19043566)
41. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350(14):1387-1397. (Pubitemid 38419992)